Form 4 for IDXX Idexx Laboratories
Accepted 2025-08-14 00:00:00 ET · period of report 2025-08-12 · accession 0000874716-25-000143 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-08-14 | 2025-08-12 | IDXX | Erickson Michael G | EVP | S - Sale | $649.96 | -405.89 | 11.4K | -3% | -$263.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-12 | S | D | 87.89 | $649.85 | 11,286.97 | D | — | — | (F2) Represents the weighted average price of the shares sold ranging from a low of $649.8492 to a high of $650.00 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 2 | Common | Common Stock | 2025-08-12 | S | D | 318 | $649.99 | 11,374.86 | D | — | — | (F1) Includes a total of 26.4960 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2025 and June 30, 2025. |